Fund, guide, and support academic researchers and entrepreneurs on the translational journey from bench to clinical practice.

As Dean’s Impact Scholar, I establish and leverage relationships between and beyond the UW to identify ways to encourage research on minority entrepreneurship in academia.

Guide practicum program students through real-world regulatory issue analysis and strategy development for professional clients.

Teach project management, realistic goal setting, and development of team synergy in capstone course series and professional engineer course to mechanical engineering seniors designing and fabricating products and systems for corporate and university project sponsors.

Pro-bono commercialization strategy advisor for California biotech, pharma, digital health, medical device startups.

Pro-bono commercialization mentorship to inventors, clinicians, students, and technology entrepreneurs who create innovative solutions for unmet clinical needs.

Oncodisc is developing implantable devices aimed at connecting patients with their care providers for improved monitoring and patient outcomes.

Founded consultancy to guide healthcare entrepreneurs from concept through commercialization, integrating market research, market opportunity assessment, clinical trial design, regulatory, reimbursement, market and distribution channel selection, pricing, and promotion.Project Samples:Intersect ENT: Created market opportunity assessment, regulatory, reimbursement, pricing, distribution, and hiring plan for European market entry of sinus infection treatment company. Sponsored by lead investor Kleiner, Perkins, Caufield, Byers.Medical Technology Venture Partners: Researched market dynamics, competitive landscapes, venture exit opportunities, and wrote investment opinions to support due diligence for venture capital fund.Morris Innovative: Identified potential investors, assisted fundraising, and recommended distribution partners for vascular access closure start-up.Neodyne Biosciences: Created clinical data summaries and promotional materials for start-up marketing direct-to-consumer scar-reducing bandage.NeuroSave: Developed market opportunity assessment, selected target market through clinical literature research, market research, interviews with physicians and hospital administrators for start-up developing brain cooling technology. Norwest Venture Partners: Conducted due diligence and wrote investment opinion of sinus surgery start-up for venture capital fund.Roxwood Medical: Created promotion strategy and collateral materials for start-up cardiovascular intervention company.Skysis: Conducted health economics analysis to gain foreign health ministry acceptance of pharmaceutical chemo-therapy alternative in cancer treatment.St. Jude Medical: Conducted market perception study of neurologists, neurosurgeons, and pain specialists to guide market entry of deep brain and spinal stimulation systems.US Asia Venture Partners: Conducted market research to select target market for client offering novel denture manufacturing technology.

Initiated and led clinical, marketing, and sales activities from first human use through European distribution and US direct sales for innovative aortic valvuloplasty balloon start-up company focused on the TAVR market.Selected initial clinical sites, authored protocols to minimize regulatory challenges, negotiated physician approval, drove rapid patient enrollment, and managed case report form collection to support regulatory submissions. Strong relationship development with world-leading cardiologists and surgeons resulted in abstract presentation and live case at TCT conference.Hired cost-efficient ad agency. Originated marketing materials, branding, sales aid copy, and brochures. Managed booth development, logistics, and staffing for several international and domestic conferences.Defined PR strategy, selected PR firm, and managed press releases, boosting customer awareness and attracting distributors and potential acquirers. Represented sales and marketing in all fundraising pitches.Created and managed Customer Service system. Trained staff to support OUS and US sales operations.Negotiated distributor contracts, achieving win-win arrangements. Provided remarkable distributor support, winning customer conversion and 20% share in active markets in first year of sales.Established US pricing and volume discount schedule based on market research study, reimbursement, and revenue goals.Acted as direct sales rep for unfilled territories, conducted product trials, negotiated with purchasing managers, and closed first US sales.Wrote job descriptions, hired, and managed US sales reps. Created compensation plan, defined territories, authored sales talk-tracks and training materials, trained and coached reps to overcome customer objections.Managed forecast for sales and manufacturing build plan based on sales data, distributor inputs, detailed market penetration model, and close coordination with operations.

Prioritized markets through quantitative and qualitative analysis of market projections, regulatory opportunities, and local economics to select top countries for OUS expansion. Set analytics-based pricing for local markets. Trained international distributors.Launched game-changing multi-angle endoscope, Cyclops, at industry leading conference AAO-HNSF, generating overwhelming excitement in the ENT community and setting sales lead record for conference.Turned-around flagging airway balloon dilation business through launch of expanded product line and peer-to-peer education program, resulting in 61% year-over-year growth.Invented, developed, and implemented iPad-based enterprise software solution, enabling sales reps to influence procedure scheduling and drive incremental sales, while satisfying surgeon community outcry for clinical data.

Executive Team member responsible for market opportunity identification and selection process, product portfolio planning and revenue projections, clinical strategy, management of international Medical Advisory Board, corporate branding, and Board Meeting marketing updates for start-up company developing Pro-Healing technologies with applications in cardiovascular, spine, ENT, gastro-intestinal, orthopedics, and urology markets.Led development engineers through product definition. Managed regulatory and reimbursement consultants through identification of product formats with shortest regulatory path and greatest profit potential for healthcare providers.

Developed strategic plan to maximize profit with shortest time to market for start-up peripheral stent company. Established Scientific Advisory Board and compensation plan. Selected ad agency, spear-headed corporate branding. Defined target customer and product positioning. Directed next-generation products based on clinical feedback. Served as senior staff member presenting market updates at Board meetings for start-up peripheral stent company.Trained physicians and proctored cases for multi-center femoropopliteal stent study in Germany and Argentina. Bi-weekly international travel and effective management of physician relationships resulted in fast enrollment and successful implantation of world’s first 250 mm stent.Conducted quantitative market research to objectively identify fast-enrolling centers for US IDE clinical study.Orchestrated successful clinical investigator meetings. Resulted in faster patient enrollment, improvement in device implant technique, and boosted physician eagerness to promote technology to potential investors.

Defined product, guided R&D, trained sales force, orchestrated market preference test. Devised innovative regulatory strategy, negotiated senior staff buy-in, reducing time to market by 1 year. Led product naming, directed ad agency logo design, and developed marketing materials for atherectomy device addressing unmet clinical need and expected to generate an incremental $25M in first year sales for fast-growth peripheral arterial disease (PAD) treatment company.Initiated and led first-ever national pricing assessment in response to customer concerns about reimbursement and procedure cost. Resulted in new pricing schedule and readily accepted objective price increase in 20% of accounts.Created and implemented sales force clinical training program to boost confidence with new product in challenging below-the-knee applications. Increased customer adoption by 30%.Developed new customer training course, directed content development, orchestrated inaugural program. Course established as new standard in peer-to-peer physician education based on resoundingly positive feedback and increased sales. Expanded program to two day course for 120 surgeon attendees. Incremental sales generated 125% ROI.

Initiated and led first-ever 3 year product and price planning based on revenue goals, prioritized market needs, and clinical adoption projections for newly acquired microwave ablation technology to treat atrial fibrillation.Leveraged marketing and product development experience to establish new, faster product development process. Cultivated organization consensus; won senior staff approval. Reduced time to market by 50%.Product manager for 4 concurrent product teams. Performed market needs assessments and competitive analysis, set pricing, created revenue forecasts and product marketing budgets, wrote IFU’s, selected packaging and labeling, named products. Defined and directed market research to guide ad campaign. Drove product definition to satisfy market needs and achieve sales targets. Presentations to senior staff resulted in approval for development of all 4 products.

Managed researchers, consultants, licensing partner. Invented, designed, machined, and tested prototypes for presentation to senior management and clinicians. Resulted in new flagship product platform expanding technology applications to treat lung, bone, breast cancer; 5 IP filings for start-up minimally-invasive cancer treatment company.Negotiated technology licensing agreement with CEO and lawyers of licensing company. Resulted in win-win contract.Managed cross-functional team through development of pioneering optical spectroscopy cancer detection device. Wrote clinical protocol and won Stanford University Hospital IRB approval. Managed clinical study. Proved feasibility.Developed devices and clinical procedures, directed pre-clinical studies, trained surgeons, managed European prostate cancer clinical trial through monthly travel to hospitals in Vienna, Brussels, and Milan. Resulted in 100% increase in patient recruitment rate, successful treatment of 40 prostate cancer patients, invigorated investor support prior to IPO.

Invented and developed innovative disposable cardiac surgical instrument and orchestrated work of cross-functional team through development cycle for start-up minimally-invasive heart surgery device company.Designed implantable and disposable anastomosis devices. Conducted design of experiments (DOE) and proved device exceeds 10-year implantation standard. Resulted in fabricated product and patent.

Designed and developed structural and cosmetic parts in injection molded plastic, sheet metal, die-cut plastic, cast urethane, machined metal, deep drawn steel, and sand-cast aluminum.Managed cost reduction project boosting profit by $400K.